Latest Conference Articles

Research Update:  Cytokine Storm Syndrome

Research Update: Cytokine Storm Syndrome

September 28th 2020

CCR

Various drug therapies, including several cytokine blockers, are showing promise in addressing COVID-19 related cytokine storm syndrome, says Dr. Randall Cron of Children’s Hospital of Alabama.

Reassessing CVD Risk in Rheumatic Disease

Reassessing CVD Risk in Rheumatic Disease

September 23rd 2020

CCR

Some drugs used to treat lupus and other connective tissue diseases have been shown to increase cardiovascular risks. Even so, those drugs remain effective in addressing disease symptoms, and a leading rheumatology researcher has suggested that concerns may not be fully warranted.

The Future of Psoriatic Arthritis Treatment

The Future of Psoriatic Arthritis Treatment

September 23rd 2020

CCR

New algorithms and more combination therapeutics are part of the future of psoriatic arthritis care. That’s according to Arthur Kavanaugh, M.D., a rheumatologist with UC San Diego Health who recently presented at the Congress of Clinical Rheumatology East annual meeting held this month.​

Study Highlights Racial Disparities in Knee OA Treatment

Study Highlights Racial Disparities in Knee OA Treatment

September 22nd 2020

CCR

Black patients with knee osteoarthritis have worse outcomes than their white counterparts, shows a new study.

Diagnostic Options for Cognitive Dysfunction in Lupus

Diagnostic Options for Cognitive Dysfunction in Lupus

September 22nd 2020

CCR

Cognitive impairment can be an ongoing issue for patients with rheumatic disease, such as lupus. A proper diagnosis includes a battery of tests, says Noa Shwartz, M.D., a physician-researcher with Albert Einstein College of Medicine in New York.

Polypharmacy Gains Favor in Lupus Nephritis

Polypharmacy Gains Favor in Lupus Nephritis

September 21st 2020

CCR

Simultaneous use of more than one drug is gaining traction as a treatment strategy for severe lupus symptoms, particularly in people with chronic kidney disease.

Mediterranean Diet Seems to Lower Fall Risk

Mediterranean Diet Seems to Lower Fall Risk

September 21st 2020

ASBMR

Adherence to a Mediterranean diet is associated with improved musculoskeletal health and fewer falls, according to study data presented at the American Society for Bone and Mineral Research (ASBMR) annual meeting held earlier this month.

Oral Glucocorticoids and Fracture Risk in RA

Oral Glucocorticoids and Fracture Risk in RA

September 21st 2020

ASBMR

Low-dose oral glucocorticoid therapy increases only vertebral fracture risk in rheumatoid arthritis patients, a study shows.

Low Osteocalcin Linked to Glucocorticoid-Induced Diabetes

Low Osteocalcin Linked to Glucocorticoid-Induced Diabetes

September 16th 2020

ASBMR

Low levels of osteocalcin are associated with an increased risk of diabetes in patients treated with glucocorticoids, according to a study presented on Sept. 11 at the American Society for Bone and Mineral Research (ASBMR) annual meeting which wrapped this week as a virtual meeting.

Low Vitamin D May Worsen COVID-19

Low Vitamin D May Worsen COVID-19

September 16th 2020

ASBMR

Improving vitamin D status might decrease the risk of developing severe respiratory distress and death in COVID-19 cases, shows an observational study presented September 11 at the American Society for Bone and Mineral Research (ASBMR) which was held virtually this week.